AJR Get Involved! Join ARRS Today
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Figures Only
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Win, T.
Right arrow Articles by Laroche, C. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Win, T.
Right arrow Articles by Laroche, C. M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Hotlight (NEW!)
Right arrow
What's Hotlight?
DOI:10.2214/AJR.04.1973
AJR 2006; 187:1260-1265
© American Roentgen Ray Society


Clinical Observations

Ventilation-Perfusion Scintigraphy to Predict Postoperative Pulmonary Function in Lung Cancer Patients Undergoing Pneumonectomy

Thida Win1, Angela D. Tasker2, Ashley M. Groves3, Carol White2, Andrew J. Ritchie4, Francis C. Wells4 and Clare M. Laroche1

1 Department of Thoracic Oncology, Papworth Hospital, Papworth Everard, Cambridge, CB3 8RE, United Kingdom.
2 Department of Radiology, Papworth Hospital, Cambridge, United Kingdom.
3 Institute of Nuclear Medicine, University College London, London, United Kingdom.
4 Department of Cardiothoracic Surgery, Papworth Hospital, Cambridge, United Kingdom.

Received December 28, 2004; accepted after revision June 13, 2005.

 
The study received funding from a National Health Service Research and Development Grant.

Address correspondence to T. Win (drthidawin{at}hotmail.com).


Abstract
Top
Abstract
Introduction
Subjects and Methods
Results
Discussion
References
 
OBJECTIVE. The American College of Chest Physicians (ACCP) recommends using quantitative perfusion scintigraphy to predict postoperative lung function in lung cancer patients with borderline pulmonary function tests who will undergo pneumonectomy. However, previous scintigraphic data were gathered on small cohorts more than a decade ago, when surgical populations were significantly different with respect to age and sex compared with typical lung cancer patients undergoing pneumonectomy in 2005. We therefore revisited the use of V/Q scintigraphy in pneumonectomy patients in predicting postoperative pulmonary function and the appropriateness of current clinical guidelines.

CONCLUSION. Contrary to ACCP guidelines, we found that ventilation scintigraphy alone provided the best correlation between the predicted and actual postoperative values and recommend its use to predict postoperative lung function. However, scintigraphic techniques may underestimate postoperative lung function, so caution is required before unnecessarily preventing a patient from undergoing surgery that offers a potential cure.

Keywords: bronchogenic carcinoma • cancer • lung disease • nuclear medicine • pneumonectomy • scintigraphy • ventilation-perfusion


Introduction
Top
Abstract
Introduction
Subjects and Methods
Results
Discussion
References
 
Patients with bronchogenic carcinoma frequently have impaired pulmonary function, usually secondary to chronic airway obstruction [1]. If these patients are referred for possible curative surgery, they are at increased risk of developing postoperative complications, and some have such poor respiratory reserve that a pneumonectomy may result in an unacceptable quality of life. Numerous techniques have been used to evaluate the postsurgical risk. These include pulmonary function tests (PFTs), exercise tests, and quantitative ventilation-perfusion (V/Q) scintigraphy.

Recent American College of Chest Physicians (ACCP) guidelines [2], as well as those from equivalent European organizations such as the British Thoracic Society (BTS) [3], recommend using quantitative Q scintigraphy in patients with borderline lung function (forced expiratory volume at 1 second [FEV1] < 2.0 L) to predict the postoperative lung function in lung cancer patients who are considering undergoing pneumonectomy. The evidence base for the ACCP and others' guidelines comes from previous V/Q scintigraphy data, much of which were obtained between 10 and 30 years ago from studies that used small numbers of participants (usually fewer than 20), with populations significantly younger and with a male predominance compared with the patients who presented for curative surgery in 2005.

The correlation between the actual and predicted postoperative FEV1 using quantitative V/Q scintigraphy has been variable, with correlative figures quoted between r = 0.67 and r = 0.9 [4-11]. Many of these investigators, however, found that the scintigraphically predicted postoperative FEV1 was lower than the actual postoperative FEV1 [4, 8, 9]. Also in the literature, we found inconsistencies in terminology and in the choice of the most useful postoperative measurement. Some investigators use scintigraphy to predict the FEV1 after pneumonectomy [8, 9], whereas others quote the predicted percentage of FEV1 (the FEV1 value predicted for a patient of a given height, sex, and age) [12-16]. Moreover, we found no clear evidence as to whether it is better to use a V scan or a Q scan alone or in combination. We therefore revisited the use of V/Q scintigraphy in pneumonectomy patients for predicting postoperative pulmonary function and the appropriateness of present clinical guidelines.


Subjects and Methods
Top
Abstract
Introduction
Subjects and Methods
Results
Discussion
References
 
Over 24 months, we prospectively performed pre- and postsurgical PFTs and quantitative planar V/Q scintigraphy on 32 patients (21 men and 11 women; mean age, 68.4 years; range, 42-85 years) who were undergoing pneumonectomy for non-small cell lung cancer. All patients were former smokers and had preoperative peak oxygen consumption (VO2 peak) greater than 10 mL/kg/min. Twelve out of 32 had FEV1 less than 2.0 L, connoting borderline lung function. Twenty-one patients underwent left pneumonectomy, and 11 underwent right pneumonectomy. All pneumonectomies were performed using a standard posterolateral thoracotomy technique by one of three designated cardiothoracic surgeons. All patients gave written consent, and the study had local ethical committee approval.


Figure 1
View larger version (57K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 1 Anterior and posterior images from perfusion scintigram. Three equally sized regions of interest over lungs are shown. Counts in each zone were measured. Geometric means of anterior and posterior images were then used to calculate relative perfusion and ventilation for each zone for each lung. By this method, percentages were obtained for upper, middle, and lower zones of right and left lungs for both perfusion and ventilation.

 
Spirometry
The FEV1 measurements were made before surgery and repeated, in the same manner, 1 month after surgery for all patients. The FEV1 was calculated from a record of forced vital capacity (FVC) performed on a wedge bellows, 12-second spirometer (Vitalograph). At least three recordings were made until the results were reproducible, and the best of three reproducible attempts was adopted.

Quantitative Planar V/Q Studies
Quantitative planar V/Q studies were performed using an Apex SP4 single-headed camera (Elscint) with a low-energy all-purpose collimator. Patients were imaged while erect, with four views obtained (anterior, posterior, and right and left posterior oblique at 30°). Qualified nuclear medicine technicians supervised all studies. Images were reported by specialists in cardiothoracic imaging.

Ventilation studies were performed using 1,200 MBq of technetium-99m (99mTc) diethylenetriamine pentaacetic acid (DTPA), which was nebulized through a Venticis II aerosol delivery system (CIS bio international) until an activity of 40 MBq could be detected in the lungs. Perfusion imaging was then performed 4 hours later by IV infusion of 75 MBq 99mTc macroaggregated albumin (MAA), with deep respiration. Images were obtained from four routine views (anterior, posterior, and right and left posterior oblique at 30°) for both the ventilation and the perfusion studies. Only the anterior and posterior views were analyzed as part of this study.

Relative perfusion and ventilation analyses were performed by obtaining three equally sized regions of interest over the lungs (Fig. 1) and by performing a geometric mean of the anterior and posterior images, thus giving relative perfusion and ventilation for the three zones in each lung. Percentage results were thereby obtained for the upper, middle, and lower zones of the right and left lungs for both the perfusion and ventilation studies.

To estimate the predicted postoperative FEV1, the following equations, described by Wernly et al.[17], were used:

Formula(1)

Formula(2)

Formula(3)

Statistical Analysis
Pearson's correlation coefficient was used for all the comparisons. Bland-Altman plots were used to establish the bias and reliability of the different scintigrams.


Results
Top
Abstract
Introduction
Subjects and Methods
Results
Discussion
References
 
The mean preoperative FEV1 was 2.13 L (SD, 0.38 L; range, 1.2-3.3 L), and the mean actual postoperative FEV1 was 1.36 L (SD, 0.36 L; range, 0.8-2.5 L). The mean preoperative percentage of predicted FEV1 was 85% (SD, 16%; range, 42-119%), and the mean actual postoperative percentage of predicted FEV1 was 53% (SD, 13%; range, 28-90%).

One death (secondary to tumor reoccurrence) occurred 6 months after surgery. None of the 31 surviving patients suffered from respiratory insufficiency during this period.

Predicted Postoperative FEV1
The mean predicted postoperative FEV1 using V scintigraphy, Q scintigraphy, and combined V/Q scintigraphy was 1.22 L (SD, 0.36 L; range, 0.55-1.79 L). 1.31 L (SD, 0.37 L; range, 0.62-2.4 L), and 1.26 L (SD, 0.32 L; range, 0.59-1.74 L), respectively (Tables 1 and 2).


View this table:
[in this window]
[in a new window]

 
TABLE 1: Measured and Predicted Postoperative FEV1 Using Ventilation-Perfusion Scintigraphy Scan

 

View this table:
[in this window]
[in a new window]

 
TABLE 2: Percentage of Predicted Postoperative FEV1 Using Ventilation-Perfusion Scintigraphy Scan

 

The correlation (r) between actual and predicted postoperative values for FEV1 was 0.7, 0.58, and 0.54 for V scintigraphy, Q scintigraphy, and combined V/Q scintigraphy, respectively (Table 3 and Fig. 2).


View this table:
[in this window]
[in a new window]

 
TABLE 3: Correlation Between Actual and Predicted Postoperative FEV1

 

Figure 2
View larger version (19K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 2 Histogram shows relationship and correlation (r) between predicted FEV1 and actual measured postoperative FEV1 using ventilation (V) scintigraphy, perfusion (Q) scintigraphy, and combined V/Q scintigraphy.

 

The Bland-Altman analysis shows the differences between V scintigraphy, Q scintigraphy, and combined V/Q scintigraphy in predicting postoperative FEV1 (Table 4). Figures 3 and 4 provide examples and further explanation.


View this table:
[in this window]
[in a new window]

 
TABLE 4: Bland-Altman Analysis of Different Methods to Predict Postoperative FEV1

 

Figure 3
View larger version (8K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 3 Bland-Altman plot of actual postoperative FEV1 (in liters) and predicted postoperative FEV1 (in liters) using ventilation scintigraphy. If this relationship were perfect (no bias), all points would lie close to zero line on x-axis. Most points lie beneath this line, indicating that ventilation scintigraphy underestimates actual postoperative lung function.

 

Figure 4
View larger version (8K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 4 Bland-Altman plot of measured FEV1 (in liters) and predicted postoperative FEV1 (in liters) using perfusion scintigraphy. Equal points lie above and beneath zero line, indicating that perfusion scintigraphy underestimates actual postoperative lung function less than ventilation scintigraphy (as seen in Fig. 3).

 

Predicted Postoperative Percentage of FEV1
The mean percentage of predicted postoperative FEV1 using V scintigraphy, Q scintigraphy, and combined V/Q scintigraphy was 49% (SD, 14%; range, 19-71%), 52% (SD, 15%, range; 22-81%), and 50% (SD, 14%; range, 21-78%), respectively (Table 1 and Fig. 5).


Figure 5
View larger version (16K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 5 Histogram shows relationship and correlation (r) between predicted percentage FEV1 and actual measured postoperative percentage of predicted FEV1 using ventilation (V) scintigraphy, perfusion (Q) scintigraphy, and combined V/Q scintigraphy.

 
The correlation (r) between the actual and the predicted percentage of FEV1 was 0.73,0.6, and 0.62, respectively, for the V scintigraphy, the Q scintigraphy, and combined V/Q scintigraphy (Table 3 and Figs. 6 and 7).


Figure 6
View larger version (11K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 6 Correlation between measured postoperative and predicted postoperative percentage of FEV1 using ventilation scintigraphy scan; r = 0.73.

 

Figure 7
View larger version (10K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 7 Correlation between measured postoperative and predicted postoperative percentage of FEV1 using perfusion scintigraphy scan; r = 0.60.

 
The Bland-Altman analysis shows the differences among V scintigraphy, Q scintigraphy, and combined V/Q scintigraphy in predicting the postoperative percentage of predicted FEV1 (Table 4).


Discussion
Top
Abstract
Introduction
Subjects and Methods
Results
Discussion
References
 
The presence of bronchogenic carcinoma causes a decrease in both ventilation and perfusion of the involved lung, especially if the lesions are in the hilar region. The lung function will further diminish with loss of lung parenchyma after a pneumonectomy procedure. Radionuclide lung quantification offers a simple method of predicting the loss in lung air capacity with quantitative measurement of differential ventilation or perfusion [13, 18]. Our study contained an older population with more female patients compared with previously reported studies and, therefore, reflects current practice. Our study population was considerably larger than that used in most previous studies [4-9] (Table 5) and also contained patients with lower FEV1 values than has been investigated previously, reflecting the impact of modern surgical techniques.


View this table:
[in this window]
[in a new window]

 
TABLE 5: Comparison of Analyses of Ventilation-Perfusion Scanning for Predicting Postoperative FEV1

 

The correlation between actual and predicted values was significant for both FEV1 and percentage of predicted FEV1 values. The correlation was not as good as that previously reported [4-9] (Table 5). The highest reported correlation was obtained from V/Q SPECT quantification [10]. Although the American College of Chest Physicians [2] and the British Thoracic Society [3] recommend using perfusion scintigraphy only, we found that the ventilation scan offered the best correlation, a finding that has been previously reported [17]. Most likely the guidelines favor perfusion scintigraphy because more reports have been published on perfusion scintigraphy [6, 7, 9, 19, 20] than on ventilation scintigraphy. The use of ventilation scintigraphy alone has the advantages of requiring a lower radiation dose and avoiding the use of needles. We also found that no added predictive advantage was gained from combining both ventilation and perfusion studies, a finding that also has been previously noted [17]. Although ventilation scintigraphy offered better correlation than perfusion scintigraphy (r = 0.7 vs 0.58), a statistically significant difference between the two tests was not seen. Therefore, it would still be acceptable to perform perfusion scintigraphy alone as is done in traditional practice.

In keeping with previous findings, we showed that scintigraphy usually predicted lower postoperative FEV1 values than what actually occurred. This tendency also has been reported by other investigators [4, 8]. This finding has potentially serious implications in deciding patients' fitness for lung cancer surgery, because underestimating patients' postoperative lung function may unnecessarily preclude them from curative surgery. Our experience suggests that this underestimation occurs both when scintigraphy is used to predict the postoperative FEV1 and when it is used to determine the percentage of predicted FEV1, although we found the latter marginally more accurate.

Improvements in the correlation between scintigraphy and pulmonary function tests may have been found by using more sophisticated techniques such as SPECT. This is a tomographic technique (similar to the principles of CT) where the gamma camera rotates around the patient's body, acquiring images in different positions. SPECT gives better target-to-nontarget ratios than do planar images. This, in turn, affords improved resolution in any given plane, better definition of shape, and accurate quantification. However, because multiple camera projections are required, imaging time is much longer than for a single planar image. Unfortunately, many institutions do not have enough camera time capacity to perform this on all such patients.

Our technique could have been further enhanced by the use of ventilation gases (e.g., 99mTc gas) rather than aerosol. Aerosols, being larger and heavier particles than gases, are more likely to undergo central airway clumping. This is especially so in patients with obstructive airway disease. Technetium-99m aerosol is used because it is a cheap and readily available tracer and does not require complicated delivery systems. It is reassuring to note that in our series, only six patients had criteria for airway obstruction and only one had evidence of clumping. Technetium-99m gas is not only more expensive, but also requires more sophisticated delivery systems because very high concentrations of tracers are needed in tiny volumes. For these reasons, our institution has greater expertise in and prefers to use aerosols. Nonetheless, our use of aerosols may, in part, have explained why our correlation figures were not as high as previously reported (Table 5). Probably the best ventilation agent would have been krypton-81m (81mKr) [10], but the availability of this agent remains limited.

In conclusion, in certain lung cancer patients being considered for pneumonectomy, and in contradiction to current American College of Chest Physician and British Thoracic Society guidelines, we recommend the use of ventilation scintigraphy alone to predict postoperative FEV1. However, it is important to note that ventilation scintigraphy tends to underestimate actual postoperative lung function and, if this underestimation is not fully appreciated, some patients may unnecessarily be deprived of curative surgery.


Acknowledgments
 
We thank Linda Sharples, PhD, Cambridge MRC, for her invaluable statistical input and Prof. Adrian Dixon, Radiology Department, University of Cambridge, for his input.


References
Top
Abstract
Introduction
Subjects and Methods
Results
Discussion
References
 

  1. Legge JS, Palmer KN. Pulmonary function in bronchial carcinoma. Thorax 1973; 28:588 -591[Abstract/Free Full Text]
  2. Beckles MA, Spiro SG, Colice GL, Rudd RM. The physiologic evaluation of patients with lung cancer being considered for resectional surgery. Chest 2003;123 : 105S-114S.
  3. British Thoracic Society, Society of Cardiothoracic Surgeons of Great Britain and Ireland Working Party. BTS guidelines: guidelines on the selection of patients with lung cancer for surgery. Thorax 2001; 56:89 -108[Free Full Text]
  4. Williams AJ, Cayton RM, Harding LK, Mostafa AB, Matthews HR. Quantitative lung scintigrams and lung function in the selection of patients for pneumonectomy. Br J Dis Chest 1984;78 : 105-112[Medline]
  5. Bria WF, Kanarek DJ, Kazemi H. Prediction of postoperative pulmonary function following thoracic operations: value of ventilation-perfusion scanning. J Thorac Cardiovasc Surg 1983; 86:186 -192[Abstract]
  6. Corris PA, Ellis DA, Hawkins T, Gibson GJ. Use of radionuclide scanning in the preoperative estimation of pulmonary function after pneumonectomy. Thorax 1987;42 : 285-291[Abstract/Free Full Text]
  7. Cordiner A, De Carlo F, De Gennaro R, Pau F, Flore F. Prediction of postoperative pulmonary function following thoracic surgery for bronchial carcinoma. Angiology 1991;42 : 985-989[Abstract/Free Full Text]
  8. Zeiher BG, Gross TJ, Kern JA, Lanza LA, Peterson MW. Predicting postoperative pulmonary function in patients undergoing lung resection. Chest 1995; 108:68 -72[Abstract/Free Full Text]
  9. Olsen GN, Block AJ, Tobias JA. Prediction of postpneumonectomy pulmonary function using quantitative macroaggregate lung scanning. Chest 1974; 66:13 -16[Abstract/Free Full Text]
  10. Bins MC, Wever AM, Pauwels EK, Van Der Velde EA. Krypton-81m ventilation studies as a parameter for lung capacity after lobectomy. Eur J Nucl Med 1984;9 : 312-315[Medline]
  11. Hirose Y, Imaeda T, Doi H, Kokubo M, Sakai S, Hirose H. Lung perfusion SPECT in predicting postoperative pulmonary function in lung cancer. Ann Nucl Med 1993;7 : 123-126[Medline]
  12. Markos J, Mullan BP, Hillman DR, et al. Preoperative assessment as a predictor of mortality and morbidity after lung resection. Am Rev Respir Dis 1989; 139:902 -910[Medline]
  13. Ali MK, Mountain CF, Ewer MS, Johnston D, Haynie TP. Predicting loss of pulmonary function after pulmonary resection for bronchogenic carcinoma. Chest 1980;77 : 337-342[Abstract/Free Full Text]
  14. Bolliger CT, Wyser C, Roser H, Soler M, Perruchoud AP. Lung scanning and exercise testing for the prediction of postoperative performance in lung resection candidates at increased risk for complications. Chest 1995; 108:341 -348[Abstract/Free Full Text]
  15. Pierce RJ, Copland JM, Sharpe K, Barter CE. Preoperative risk evaluation for lung cancer resection: predicted postoperative product as a predictor of surgical mortality. Am J Respir Crit Care Med 1994; 150:947 -955[Abstract]
  16. Pate P, Tenholder MF, Griffin JP, Eastridge CE, Weiman DS. Preoperative assessment of the high-risk patient for lung resection. Ann Thorac Surg 1996;61 : 1494-1500[Abstract/Free Full Text]
  17. Wernly JA, Demeester TR, Kirchner PT, Myerowitz PD, Oxford DE, Golomb HM. Clinical value of quantitative ventilation-perfusion lung scans in the surgical management of bronchogenic carcinoma. J Thorac Cardiovasc Surg 1980; 80:535 -543[Medline]
  18. Taube K, Konietzko N. Prediction of postoperative cardiopulmonary function in patients undergoing pneumonectomy. Thorac Cardiovasc Surg 1980; 28:348 -351[Medline]
  19. Boysen PG, Harris JO, Block AJ, Oslen GN. Prospective evaluation for pneumonectomy using perfusion scanning: follow-up beyond one year. Chest 1981; 80:163 -166[Abstract/Free Full Text]
  20. Boysen PG, Block AJ, Oslen GN, Moulder PV, Harris JO, Rawitscher RE. Prospective evaluation for pneumonectomy using the 99m technetium quantitative perfusion lung scan. Chest1977; 72:422 -425[Abstract/Free Full Text]

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Eur Respir JHome page
A. Brunelli, A. Charloux, C. T. Bolliger, G. Rocco, J-P. Sculier, G. Varela, M. Licker, M. K. Ferguson, C. Faivre-Finn, R. M. Huber, et al.
ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy)
Eur. Respir. J., July 1, 2009; 34(1): 17 - 41.
[Abstract] [Full Text] [PDF]


Home page
J. Nucl. Med. Technol.Home page
A. MacDonald and S. Burrell
Infrequently Performed Studies in Nuclear Medicine: Part 2
J. Nucl. Med. Technol., March 1, 2009; 37(1): 1 - 13.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Figures Only
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Win, T.
Right arrow Articles by Laroche, C. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Win, T.
Right arrow Articles by Laroche, C. M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Hotlight (NEW!)
Right arrow
What's Hotlight?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS